Cargando…
Statins and New-Onset Diabetes Mellitus: LDL Receptor May Provide a Key Link
Numerous studies have noted that populations treated with statins have increased risk for new-onset diabetes mellitus; however, the underlying molecular mechanisms are not fully understood. Interestingly, familial hypercholesterolemia (FH) patients with mutations in the low-density lipoprotein recep...
Autores principales: | Yu, Qi, Chen, Ying, Xu, Cang-Bao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468445/ https://www.ncbi.nlm.nih.gov/pubmed/28659805 http://dx.doi.org/10.3389/fphar.2017.00372 |
Ejemplares similares
-
Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Beernink, Jelle M., et al.
Publicado: (2022) -
Statins and Risk of New-Onset Diabetes Mellitus: is there a Rationale for Individualized Statin Therapy?
por: Navarese, Eliano Pio, et al.
Publicado: (2013) -
Clinical and economic impact of changing reimbursement criteria for statin treatment among patients with type 2 diabetes mellitus in South Korea
por: Kim, Siin, et al.
Publicado: (2022) -
Statins may be a key therapeutic for Covid-19
por: Gordon, David
Publicado: (2020) -
Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland
por: Ruokoniemi, Päivi, et al.
Publicado: (2014)